Global Acute Heart Failure (AHF) Therapeutics Market Research Report 2015-2025
- HEY3836103
- 88 Pages
- April 2020
- Healthcare
The global Acute Heart Failure (AHF) Therapeutics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Home Care
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Acute Heart Failure (AHF) Therapeutics Picture
1.1.2 Specifications
Table Product Specifications of Acute Heart Failure (AHF) Therapeutics
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Market by Type, 2011-2022 (USD Million)
1.2.1.1 B-Blockers
Table B-Blockers Overview
1.2.1.2 Calcium Channel Blockers
Table Calcium Channel Blockers Overview
1.2.1.3 Cardiac Glycosides
Table Cardiac Glycosides Overview
1.2.1.4 Diuretics
Table Diuretics Overview
1.2.1.5 Morphine
Table Morphine Overview
1.2.1.6 Vasodilators/Nitrates
Table Vasodilators/Nitrates Overview
1.2.1.7 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Clinic
Table Clinic Overview
1.2.2.3 Home Care
Table Home Care Overview
1.2.3 by Regions
Table Global Acute Heart Failure (AHF) Therapeutics Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Acute Heart Failure (AHF) Therapeutics
2.2 Upstream
Table Cost of Acute Heart Failure (AHF) Therapeutics
Figure Manufacturing Process of Acute Heart Failure (AHF) Therapeutics
2.3 Market
2.3.1 SWOT
Figure SWOT of Acute Heart Failure (AHF) Therapeutics
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Acute Heart Failure (AHF) Therapeutics
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Acute Heart Failure (AHF) Therapeutics
3.4 Market Entry
Table Market Entry of Acute Heart Failure (AHF) Therapeutics
4 Market Segmentation by Type
4.1 Market Size
4.1.1 B-Blockers Market, 2013-2018
Figure B-Blockers Market Size and Growth, 2015-2019 (USD Million)
Figure B-Blockers Market Size and Growth, 2015-2019 (in Volume)
Table B-Blockers CAGR by Revenue and Volume, 2015-2019
4.1.2 Calcium Channel Blockers Market, 2013-2018
Figure Calcium Channel Blockers Market Size and Growth, 2015-2019 (USD Million)
Figure Calcium Channel Blockers Market Size and Growth, 2015-2019 (in Volume)
Table Calcium Channel Blockers CAGR by Revenue and Volume, 2015-2019
4.1.3 Cardiac Glycosides Market, 2013-2018
Figure Cardiac Glycosides Market Size and Growth, 2015-2019 (USD Million)
Figure Cardiac Glycosides Market Size and Growth, 2015-2019 (in Volume)
Table Cardiac Glycosides CAGR by Revenue and Volume, 2015-2019
4.1.4 Diuretics Market, 2013-2018
Figure Diuretics Market Size and Growth, 2015-2019 (USD Million)
Figure Diuretics Market Size and Growth, 2015-2019 (in Volume)
Table Diuretics CAGR by Revenue and Volume, 2015-2019
4.1.5 Morphine Market, 2013-2018
Figure Morphine Market Size and Growth, 2015-2019 (USD Million)
Figure Morphine Market Size and Growth, 2015-2019 (in Volume)
Table Morphine CAGR by Revenue and Volume, 2015-2019
4.1.6 Vasodilators/Nitrates Market, 2013-2018
Figure Vasodilators/Nitrates Market Size and Growth, 2015-2019 (USD Million)
Figure Vasodilators/Nitrates Market Size and Growth, 2015-2019 (in Volume)
Table Vasodilators/Nitrates CAGR by Revenue and Volume, 2015-2019
4.1.7 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Others Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 B-Blockers Market Forecast, 2020-2025
Figure B-Blockers Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure B-Blockers Market Estimates and Forecasts, 2020-2025 (in Volume)
Table B-Blockers CAGR by Revenue and Volume, 2012-2024
4.2.2 Calcium Channel Blockers Market Forecast, 2020-2025
Figure Calcium Channel Blockers Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Calcium Channel Blockers Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Calcium Channel Blockers CAGR by Revenue and Volume, 2012-2024
4.2.3 Cardiac Glycosides Market Forecast, 2020-2025
Figure Cardiac Glycosides Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cardiac Glycosides Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cardiac Glycosides CAGR by Revenue and Volume, 2012-2024
4.2.4 Diuretics Market Forecast, 2020-2025
Figure Diuretics Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Diuretics Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Diuretics CAGR by Revenue and Volume, 2012-2024
4.2.5 Morphine Market Forecast, 2020-2025
Figure Morphine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Morphine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Morphine CAGR by Revenue and Volume, 2012-2024
4.2.6 Vasodilators/Nitrates Market Forecast, 2020-2025
Figure Vasodilators/Nitrates Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Vasodilators/Nitrates Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Vasodilators/Nitrates CAGR by Revenue and Volume, 2012-2024
4.2.7 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
Figure Hospital Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2015-2019
5.1.2 Clinic Market, 2013-2018
Figure Clinic Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2015-2019
5.1.3 Home Care Market, 2013-2018
Figure Home Care Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Home Care CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2020-2025
Figure Hospital Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2020-2025
5.2.2 Clinic Market Forecast, 2020-2025
Figure Clinic Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2020-2025
5.2.3 Home Care Market Forecast, 2020-2025
Figure Home Care Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Home Care Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Home Care CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Acute Heart Failure (AHF) Therapeutics Market by Vendors, 2015-2019 (in Volume)
Table Global Acute Heart Failure (AHF) Therapeutics Market Share by Vendors, 2015-2019 (USD Million)
Table Global Acute Heart Failure (AHF) Therapeutics Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Acute Heart Failure (AHF) Therapeutics Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bayer AG
Table Bayer AG Profile List
Table Microecological Modulator Operating Data of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Bristol-Myers Squibb Company
Table Bristol-Myers Squibb Company Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Cardiorentis AG
Table Cardiorentis AG Profile List
Table Microecological Modulator Operating Data of Cardiorentis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 CVie Therapeutics Limited
Table CVie Therapeutics Limited Profile List
Table Microecological Modulator Operating Data of CVie Therapeutics Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Cytokinetics, Inc.
Table Cytokinetics, Inc. Profile List
Table Microecological Modulator Operating Data of Cytokinetics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Merck & Co.
Table Merck & Co. Profile List
Table Microecological Modulator Operating Data of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Novartis AG
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Orion Corporation
Table Orion Corporation Profile List
Table Microecological Modulator Operating Data of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 PhaseBio Pharmaceuticals, Inc
Table PhaseBio Pharmaceuticals, Inc Profile List
Table Microecological Modulator Operating Data of PhaseBio Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Acute Heart Failure (AHF) Therapeutics
Table Products Segment of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Market by Type, 2011-2022 (USD Million)
Table B-Blockers Overview
Table Calcium Channel Blockers Overview
Table Cardiac Glycosides Overview
Table Diuretics Overview
Table Morphine Overview
Table Vasodilators/Nitrates Overview
Table Others Overview
Table Application Segment of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Market by Application, 2011-2022 (USD Million)
Table Hospital Overview
Table Clinic Overview
Table Home Care Overview
Table Global Acute Heart Failure (AHF) Therapeutics Market by Region, 2011-2022 (USD Million)
Table Cost of Acute Heart Failure (AHF) Therapeutics
Table Market Dynamics
Table Policy of Acute Heart Failure (AHF) Therapeutics
Table GDP of Major Countries
Table Technology of Acute Heart Failure (AHF) Therapeutics
Table Market Entry of Acute Heart Failure (AHF) Therapeutics
Table B-Blockers CAGR by Revenue and Volume, 2015-2019
Table Calcium Channel Blockers CAGR by Revenue and Volume, 2015-2019
Table Cardiac Glycosides CAGR by Revenue and Volume, 2015-2019
Table Diuretics CAGR by Revenue and Volume, 2015-2019
Table Morphine CAGR by Revenue and Volume, 2015-2019
Table Vasodilators/Nitrates CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table B-Blockers CAGR by Revenue and Volume, 2012-2024
Table Calcium Channel Blockers CAGR by Revenue and Volume, 2012-2024
Table Cardiac Glycosides CAGR by Revenue and Volume, 2012-2024
Table Diuretics CAGR by Revenue and Volume, 2012-2024
Table Morphine CAGR by Revenue and Volume, 2012-2024
Table Vasodilators/Nitrates CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2015-2019
Table Clinic CAGR by Revenue and Volume, 2015-2019
Table Home Care CAGR by Revenue and Volume, 2015-2019
Table Hospital CAGR by Revenue and Volume, 2020-2025
Table Clinic CAGR by Revenue and Volume, 2020-2025
Table Home Care CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Acute Heart Failure (AHF) Therapeutics Market by Vendors, 2015-2019 (in Volume)
Table Global Acute Heart Failure (AHF) Therapeutics Market Share by Vendors, 2015-2019 (USD Million)
Table Global Acute Heart Failure (AHF) Therapeutics Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Bayer AG Profile List
Table Microecological Modulator Operating Data of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cardiorentis AG Profile List
Table Microecological Modulator Operating Data of Cardiorentis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CVie Therapeutics Limited Profile List
Table Microecological Modulator Operating Data of CVie Therapeutics Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cytokinetics, Inc. Profile List
Table Microecological Modulator Operating Data of Cytokinetics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Profile List
Table Microecological Modulator Operating Data of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Orion Corporation Profile List
Table Microecological Modulator Operating Data of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PhaseBio Pharmaceuticals, Inc Profile List
Table Microecological Modulator Operating Data of PhaseBio Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
